… , 100% oxygen, and inhaled bronchodilators for bronchospasm. The physical examination
… , is extremely hazardous to the eyes. Therefore, following ocular irrigation in symptomatic …

… in terms ECOPD risk reduction [130, 137], we would support the addition of ICS to long-acting
bronchodilator therapy in those patients who still experience ECOPD despite appropriate …

… a risk of cataract. Whether low doses of inhaled corticosteroids are associated with an increased
risk … to quantify the risk of cataract associated with the use of inhaled corticosteroids and …

… the relative risk of theophylline and inhaled &-agonists, we performed a clinical trial of
albuterol, … Rapid naming under interference conditions Visual association and rapid visual-motqr …

… allergic nasal, eye, and skin … of inhaled bronchodilator in the morning (Salbutamol 0.4
mg, Buventol easyhaler 0.1 mg/dos, Orion Pharma, Espoo, Finland).19 After bronchodilator …

… nebulized epinephrine with nebulized salbutamol (albuterol) or … , Philadelphia, Pa,
nebulized albuterol has been the standard of … vs albuterol; relative risk, 0.45; 95% CI, 0.14-1.41). …

… Short-acting inhaled bronchodilators (short-acting β 2 -… was evaluated by means of the visual
inspection of funnel plots. A … Our analysis showed an increase in the risk of pneumonia with …

… hazards. Airborne concentrations of HF, even at fairly low levels, lead to rapid onset of eye,
… for irritating symptoms, and inhaled bronchodilators for bronchospasm constitute general …

… of inhaled β-agonist therapy were helpful in predicting when the cough was due to asthma.
… and selfassessment of cough severity using a visual analog scale, subjects were randomized …

… fenoterol was associated with a 5-fold increase in the risk of exacerbation. After adjustment
… in risk. There was no excess risk of asthma exacerbation associated with inhaled albuterol. …